Outcome
    Moderate Evidence

    Zinc for Pathogen Resistance

    Zinc lozenges started within 24 hours of symptoms shorten colds by roughly a day; long-term use is not advisable.

    Overview

    Zinc has two distinct roles against pathogens and conflating them causes most of the confusion. As a lozenge started within about 24 hours of symptom onset, zinc shortens the duration of a common cold by roughly a day in pooled trial data. As a daily nutrient, adequate zinc status is required for normal T-cell development and function, and deficiency measurably impairs resistance to infection. Neither of these makes continuous high-dose zinc a good idea. The lozenge protocol is short-course and symptom-triggered, while long-term supplementation above modest doses causes copper deficiency. The useful framing is: correct dietary inadequacy at 15-25 mg daily, and reserve 75 mg lozenge regimens for the first week of an actual cold.

    Verdict

    Likely effective

    Meta-analyses of randomised trials show zinc lozenges shorten common cold duration when started early, with zinc acetate and adequate elemental dose mattering. Long-term high-dose use is not supported.

    Timing decides whether it works

    Lozenges started within 24 hours of the first symptoms shorten colds. Started on day three, they do essentially nothing.

    How It Works

    Free zinc ions released in the nasopharynx interfere with rhinovirus replication and appear to disrupt ICAM-1 mediated attachment to epithelial cells. This is a local, concentration-dependent effect, which is why the lozenge format matters — swallowed capsules do not deliver ionic zinc to the pharyngeal mucosa, and formulations with binders such as citric acid chelate the zinc and blunt release. Systemically, zinc is required for thymulin activity, T-cell maturation and normal neutrophil and natural killer cell function. Deficiency produces thymic atrophy and impaired cell-mediated immunity, which is why the largest infection benefits in supplementation trials appear in populations with poor zinc intake.

    Pathways involved

    Rhinovirus replication inhibition
    ICAM-1 attachment interference
    Local ionic zinc release in the pharynx
    Thymulin and T-cell maturation
    Neutrophil and NK cell function
    Copper-zinc competition for absorption

    Dosing & Protocol

    For cold duration, the trials that worked used roughly 75 mg or more of elemental zinc per day, split into lozenges taken every two to three hours while awake, starting within 24 hours of the first symptom and continuing no longer than seven days. Zinc acetate performed at least as well as gluconate in comparative meta-analysis. Formulation is decisive. Lozenges that contain citric acid, tartaric acid, sorbitol or mannitol bind zinc and prevent ionic release, and several negative trials used exactly those products. For general maintenance where dietary intake is low, 15-25 mg daily is the relevant dose and should not be confused with the lozenge protocol.
    ScenarioDoseFormTiming
    Acute cold, first 24 hours75 mg or more elemental dailyZinc acetate or gluconate lozengesEvery 2-3 hours while awake, max 7 days
    Low dietary intake maintenance15-25 mg elemental dailyZinc picolinate or citrateWith food
    Vegetarian or vegan diets15-25 mg elemental dailyAny well-absorbed saltWith food, away from high-phytate meals
    Not recommendedAbove 40 mg daily long termAny formRisk of copper deficiency
    1. 1

      Keep lozenges on hand before you need them· In advance

      The 24-hour window is too short to rely on buying them once symptoms start.

    2. 2

      Check the ingredient list· At purchase

      Avoid citric acid, tartaric acid, sorbitol and mannitol, which bind zinc and prevent ionic release.

    3. 3

      Dissolve one lozenge every 2-3 hours from symptom onset· Days 1-7

      Let it dissolve slowly in the mouth rather than chewing or swallowing it.

    4. 4

      Stop at seven days· Day 7

      Longer courses at this dose risk copper depletion and offer no further benefit.

    Do not take 75 mg daily as a routine

    The high-dose regimen is a seven-day acute protocol. Ongoing intake above 40 mg daily depletes copper and can cause anaemia and neurological problems.

    Evidence

    Two meta-analyses of randomised trials underpin the recommendation. The broader systematic review of zinc for the common cold found a reduction in symptom duration with zinc compared with placebo, while the analysis comparing zinc acetate and zinc gluconate examined the role of dosage and concluded that both salts shortened colds when the elemental dose was sufficient. Heterogeneity across trials is largely explained by formulation and timing rather than by any real disagreement about whether zinc works. Studies using chelating excipients, inadequate elemental doses or late initiation account for most null results. What the evidence does not show is prevention: zinc lozenges shorten colds, they do not reliably stop you catching them.

    Linked evidence for this pairing.

    Zinc for the common cold: a systematic review and meta-analysis of randomized controlled trials

    Score: 7/10
    2017
    meta_analysis
    n=199

    Hemila H

    High-dose zinc acetate lozenges shortened cold duration by roughly 33% versus placebo

    View source

    Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage

    Score: 7/10
    2017
    meta_analysis

    Hemila H

    High-dose zinc acetate or gluconate lozenges shortened common cold duration by about 33 percent.

    View source
    Best available evidence
    Meta-analyses of randomised controlled trials of zinc lozenges
    Typical effect
    Approximately one day shorter cold duration when started within 24 hours
    Studied dose
    75 mg or more elemental zinc daily in divided lozenges
    Time to effect
    Within days of onset
    Certainty of evidence
    Moderate; heterogeneity driven by formulation and timing

    Safety

    Short-course lozenges commonly cause a metallic taste, mouth irritation and nausea, and these are the main reason people stop. They resolve when the course ends. The important risk is chronic. Zinc competes with copper for intestinal absorption, and sustained intake above around 40 mg daily can produce copper deficiency with sideroblastic anaemia, neutropenia and myelopathy. Intranasal zinc products are a separate matter entirely and should be avoided, having been linked to lasting loss of smell.

    Reported effects

    Metallic taste and mouth irritation
    Nausea on an empty stomach
    Copper deficiency with chronic high doses
    Upper limit 40 mg elemental daily long term
    Avoid intranasal zinc (anosmia risk)
    Not a preventive for colds

    Interactions & Conflicts

    Zinc both blocks and is blocked by other minerals and several drug classes in the gut. Almost all of it is solved by separating doses in time, with the exception of copper, where the interaction is nutritional and depends on how long you supplement rather than on timing.
    Interacts withSeverityMechanismAction
    ——
    ——
    ——
    ——
    ——

    References

    1. DOI: 10.1177/2054270417694291
    2. DOI: 10.1177/2054270417694291

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.